These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 312268)

  • 1. Relationships among differentiated T-cell subpopulations. IV. Preferential induction of delayed footpad reaction to xenografts and its radioresistant nature.
    Terasaka R; Nomoto K; Himeno K; Takeya T
    Immunology; 1979 Apr; 36(4):699-705. PubMed ID: 312268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of differentiated T-cell subpopulations: difference in radiosensitivity of immune responses to allogeneic antigen.
    Taniguchi K; Nomoto K; Kubo C; Nanishi F
    Jpn J Exp Med; 1981 Feb; 51(1):45-51. PubMed ID: 6975841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationships among differentiated T-cell subpopulations. V. T-cell dependent mechanism of xenograft rejection and its radioresistant nature.
    Terasaka R; Nomoto K; Himeno K
    Immunology; 1979 Dec; 38(4):773-9. PubMed ID: 316419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells.
    Nanishi F; Nomoto K; Taniguchi K; Kubo C
    Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationships among differentiated T-cell subpopulations. I. Dissociated development of tuberculin type hypersensitivity, Jones-Mote type hypersensitivity and activation of helper function.
    Ohmichi Y; Nomoto K; Yamada H; Takeya K
    Immunology; 1976 Jul; 31(1):101-10. PubMed ID: 800398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships among differentiated T-cell subpopulations. III. Radioresistance of delayed hypersensitivity to heterologous erythrocytes.
    Nomoto K; Taniguchi K; Kubo C; Takeya K
    Immunology; 1978 Mar; 34(3):517-21. PubMed ID: 305892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells.
    Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K
    J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Delayed hypersensitivity reaction to transplantation antigens in mice with induced tolerance for allo- and xenografts].
    Liadova IV; Cherniakhovskaia IIu; Golan V
    Biull Eksp Biol Med; 1986 Oct; 102(10):452-5. PubMed ID: 2945600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro.
    Cruse JM; Whitten HD; Lewis GK; Watson ES
    Transplant Proc; 1973 Mar; 5(1):961-7. PubMed ID: 4695960
    [No Abstract]   [Full Text] [Related]  

  • 10. Selective blocking of T cell-mediated in vitro cytotoxicity to a xenogeneic tumour by anti-immunoglobulin sera.
    Newlands ES; Hay FC; Roitt IM
    Clin Exp Immunol; 1978 Feb; 31(2):189-96. PubMed ID: 306324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rejection mechanisms of xenogeneic tissue antigens in mice (author's transl)].
    Terasaka R
    Fukuoka Igaku Zasshi; 1980 Jul; 71(7):365-81. PubMed ID: 6971245
    [No Abstract]   [Full Text] [Related]  

  • 12. Sensitization of rat T cells to syngeneic tumor cultures by cocultivation in diffusion chambers.
    Cornain S; Becker S; Klein E
    Z Immunitatsforsch Immunobiol; 1977 Sep; 153(3):248-64. PubMed ID: 145105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen.
    Konda S; Nakao Y; Smith RT
    Cancer Res; 1973 Oct; 33(10):2247-56. PubMed ID: 4147496
    [No Abstract]   [Full Text] [Related]  

  • 14. Immune responses to soluble tumor antigens in various stages of tumor growth.
    Brannen GE; Santos GW
    Invest Urol; 1975 Sep; 13(2):79-84. PubMed ID: 1184342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facilitation reaction (enhancing antibodies and suppressor cells) and rejection reaction (sensitized cells) from the mother to the paternal antigens of the conceptus.
    Chaouat G; Voisin GA; Escalier D; Robert P
    Clin Exp Immunol; 1979 Jan; 35(1):13-24. PubMed ID: 371881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of xenograft rejection. I. Augmented cytotoxicity of peritoneal T cells after intraperitoneal injection of booster antigen and/or proteose peptone.
    Terasaka R; Himeno K; Shiraishi M; Nomoto K
    Jpn J Exp Med; 1981 Apr; 51(2):75-80. PubMed ID: 6974262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LY-2+ effectors cytotoxic for syngeneic tumor cells: generation by allogeneic stimulation and by supernatants from mixed leukocyte cultures.
    Hurrell SM; Zarling JM
    J Immunol; 1983 Aug; 131(2):1017-23. PubMed ID: 6223084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specificity of cell-mediated transplantation reactions. I. Studies with the technique of inhibition of migration and an assay of tumour immunity in vivo.
    Lake P; Sabbadini E; Sehon AH
    Immunology; 1974 Sep; 27(3):427-39. PubMed ID: 4137936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary cytotoxic tumor immune response induced in vitro.
    Röllinghoff M
    J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.